KEGG: sce:YLR225C
STRING: 4932.YLR225C
YLR225C refers to an uncharacterized SVF1-like protein found in Saccharomyces cerevisiae (Baker's yeast). This protein is studied primarily to understand cellular functions in yeast as a model organism. The antibody against YLR225C allows researchers to detect, quantify, and characterize this protein in various experimental contexts. While the precise function remains under investigation, structural analysis suggests similarities to the SVF1 protein family, which is involved in cell survival pathways. Research utilizing YLR225C antibodies contributes to our understanding of basic yeast biology and potentially conserved eukaryotic cellular mechanisms .
YLR225C antibody has been validated for several experimental techniques, with ELISA and Western Blot being the primary applications. For Western Blot analysis, the antibody enables detection of native and recombinant YLR225C protein in yeast cell lysates. ELISA applications include quantitative measurement of YLR225C in complex biological samples. While not explicitly validated in the provided data, researchers may explore applications such as immunoprecipitation, immunofluorescence, and chromatin immunoprecipitation with appropriate optimization. Each application requires specific protocols and controls to ensure specificity and reproducibility of results .
For maximum stability and retention of immunoreactivity, YLR225C antibody should be stored at -20°C or -80°C immediately upon receipt. The antibody is supplied in a protective buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4, which helps maintain protein stability during freeze-thaw cycles. Repeated freeze-thaw cycles should be avoided as they can lead to antibody degradation and loss of binding capacity. For short-term use (1-2 weeks), aliquots may be stored at 4°C. Creating multiple small-volume aliquots upon initial thawing is recommended to minimize freeze-thaw cycles for the stock solution .
Prior to experimental use, the antibody vial should be centrifuged briefly if any liquid becomes entrapped in the vial cap during shipment or storage. For Western Blot applications, the antibody is typically diluted in blocking buffer containing 1-5% BSA or non-fat dry milk in TBST or PBST. For ELISA, dilution in the appropriate assay buffer is recommended. Optimal working dilutions should be determined experimentally for each specific application, starting with manufacturer recommendations. Fresh dilutions should be prepared for each experiment, and any remaining diluted antibody should be discarded after use to maintain consistency between experiments .
When designing experiments to detect YLR225C with high specificity, researchers should implement several validation strategies. First, inclusion of appropriate negative controls is essential—using lysates from YLR225C knockout strains or pre-adsorption of the antibody with recombinant YLR225C protein. Second, confirming the detected band's molecular weight matches the predicted size of YLR225C (~35 kDa, though post-translational modifications may alter migration). Third, employing multiple detection methods—if Western blot detects a band, confirmation via mass spectrometry can provide additional validation. Finally, cross-validation with a second YLR225C antibody raised against a different epitope can significantly enhance confidence in results. The polyclonal nature of this antibody means it recognizes multiple epitopes, which can be advantageous for detection but may increase background in certain applications .
Non-specific binding represents a common challenge when working with polyclonal antibodies like anti-YLR225C. To address this issue, implement the following optimization steps:
| Troubleshooting Approach | Methodology | Expected Outcome |
|---|---|---|
| Blocking optimization | Test various blocking agents (BSA, non-fat milk, commercial blockers) at 3-5% concentration | Reduced background signal while maintaining specific binding |
| Antibody titration | Create a dilution series (1:500 to 1:5000) to identify optimal concentration | Determination of minimum concentration providing specific signal |
| Secondary antibody controls | Run controls with secondary antibody only | Identification of potential secondary antibody cross-reactivity |
| Wash stringency | Increase TBST/PBST concentration (0.1% to 0.3% Tween-20) and wash duration | Removal of weakly bound antibodies without affecting specific binding |
| Pre-adsorption | Incubate antibody with non-target proteins from sample | Sequestration of antibodies that bind non-specifically |
Additionally, for particularly challenging samples, consider using protein A/G pre-clearing of lysates before antibody incubation to remove components that bind non-specifically to antibody constant regions .
When designing co-immunoprecipitation (Co-IP) experiments to investigate YLR225C protein interactions, several methodological considerations can improve success rates. First, lysis buffer composition is critical—phosphate buffers at physiological pH (7.2-7.4) with 150mM NaCl are typically suitable, but detergent selection requires careful consideration. Non-ionic detergents (0.5-1% NP-40 or Triton X-100) generally preserve protein-protein interactions, while ionic detergents may disrupt them. Second, antibody coupling to solid support (protein A/G beads or magnetic beads) should be optimized for orientation and density. Pre-clearing lysates with beads alone reduces non-specific binding.
For YLR225C specifically, being an uncharacterized protein, preliminary experiments should determine whether the antibody epitope overlaps with protein interaction domains, which could interfere with Co-IP. Cross-linking the antibody to beads using dimethyl pimelimidate can prevent antibody leaching and contamination of eluted samples. Finally, elution conditions should be optimized—mild acidic elution (pH 2.5-3.0 glycine buffer) followed by immediate neutralization often preserves both antibody integrity and protein interactions for downstream analysis .
For quantitative analysis of YLR225C expression across experimental conditions, several methodological approaches can be employed:
Western Blot Densitometry: For semi-quantitative analysis, perform Western blots with the YLR225C antibody alongside a housekeeping protein control (such as actin or GAPDH for yeast). Analyze band intensities using software like ImageJ, normalizing YLR225C signal to the housekeeping protein. This approach provides relative expression changes rather than absolute quantities.
Quantitative ELISA: For more precise quantification, develop a sandwich ELISA using the YLR225C antibody as either capture or detection antibody. A standard curve using recombinant YLR225C protein enables absolute quantification within the linear range of detection.
Multiplexed Protein Analysis: For higher throughput, techniques such as protein microarrays or bead-based assays can be developed using the YLR225C antibody alongside antibodies for other proteins of interest.
The table below summarizes key parameters for quantitative Western blot analysis of YLR225C:
| Parameter | Recommended Setting | Considerations |
|---|---|---|
| Protein loading | 20-50 μg total protein | Confirm linearity with titration experiment |
| Antibody dilution | 1:1000 (optimize based on lot) | Higher dilutions may reduce background |
| Exposure time | Multiple exposures | Ensure signal is within linear range |
| Normalization | Ratio to housekeeping protein | Select stable reference appropriate for conditions |
| Replicates | Minimum of 3 biological replicates | Calculate mean ± standard deviation |
Statistical analysis should include tests appropriate for the experimental design (t-test, ANOVA) and should account for multiple comparisons when necessary .
YLR225C is classified as an uncharacterized SVF1-like protein in Saccharomyces cerevisiae. While specific function details remain limited in the current literature, structural analysis suggests homology to the SVF1 protein family, which has been implicated in cell survival processes and stress responses. Understanding YLR225C function represents an active area of research, with the antibody serving as a critical tool for exploring expression patterns under various environmental conditions and genetic backgrounds. Preliminary studies indicate potential roles in cellular stress response pathways, though comprehensive characterization requires additional investigation. Researchers interested in YLR225C function should consider combining antibody-based approaches with genetic techniques such as gene knockout or mutation studies to establish functional relationships .
Phosphorylation Analysis: For detecting phosphorylated YLR225C, researchers should combine immunoprecipitation with the YLR225C antibody followed by immunoblotting with phospho-specific antibodies (anti-phospho-serine/threonine/tyrosine).
Mass Spectrometry Validation: For definitive PTM identification, immunoprecipitate YLR225C using the antibody, followed by tryptic digestion and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis.
PTM-Specific Detection: For studies focused on specific PTMs, consider using PTM-enrichment techniques (e.g., phosphopeptide enrichment) prior to analysis.
It's important to note that if a PTM occurs within the epitope region recognized by the antibody, detection efficiency may be reduced or eliminated. Preliminary experiments comparing detection of recombinant unmodified YLR225C versus cell-derived protein can provide insights into potential recognition differences .
The YLR225C antibody has been specifically raised against and validated for Saccharomyces cerevisiae (strain ATCC 204508/S288c). Cross-reactivity with YLR225C homologs in other yeast species has not been comprehensively characterized in the provided data. When considering use with other Saccharomyces strains or species, sequence homology analysis should be performed to predict potential cross-reactivity. Greater sequence conservation in the epitope region(s) increases the likelihood of cross-reactivity, but experimental validation is essential.
For researchers working with multiple yeast species, a preliminary Western blot analysis comparing lysates from different species can provide critical information about cross-reactivity. Additionally, pre-adsorption controls, where the antibody is pre-incubated with recombinant YLR225C protein before use in the detection protocol, can help confirm signal specificity. If cross-reactivity is detected but specificity is required, immunodepletion strategies using recombinant YLR225C can sometimes improve specificity for non-target species applications .
| Complementary Method | Principle | Advantage |
|---|---|---|
| Mass Spectrometry | Peptide fingerprinting of immunoprecipitated proteins | Direct protein identification independent of antibody specificity |
| Genetic Tagging | Expression of epitope-tagged YLR225C | Detection using well-characterized tag antibodies |
| Gene Expression Analysis | RT-qPCR for YLR225C mRNA levels | Correlation between transcript and protein levels |
| CRISPR/Cas9 Knockout | Generation of YLR225C-null control samples | Definitive negative control for antibody specificity |
| Fluorescent Protein Fusion | YLR225C-GFP/RFP fusion protein expression | Visualization without reliance on antibodies |
When discrepancies arise between antibody-based detection and complementary methods, consider factors such as post-transcriptional regulation (affecting mRNA-protein correlation), antibody accessibility to epitopes, or protein turnover rates. Integrating multiple approaches provides a more complete and reliable characterization of YLR225C biology .
Effective sample preparation is critical for reliable YLR225C detection in yeast lysates. The following protocol has been optimized for Western blot applications:
Cell Harvesting: Collect yeast cells during logarithmic growth phase (OD600 0.6-0.8) by centrifugation (3000g, 5 minutes, 4°C).
Cell Lysis: Resuspend cell pellet in ice-cold lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1mM EDTA, 1% Triton X-100) supplemented with protease inhibitors (1mM PMSF, 1μg/ml leupeptin, 1μg/ml pepstatin A).
Mechanical Disruption: Add acid-washed glass beads (0.5mm diameter) to the cell suspension and vortex 8-10 times in 30-second bursts with 30-second cooling periods on ice.
Clarification: Centrifuge lysate at 12,000g for 10 minutes at 4°C to remove cell debris.
Protein Quantification: Determine protein concentration using Bradford or BCA assay.
For particularly challenging samples, consider these modifications:
For heavily glycosylated samples, add N-glycosidase F treatment step
For samples with high lipid content, include an additional detergent (0.1% SDS) in the lysis buffer
For phosphorylation studies, include phosphatase inhibitors (10mM NaF, 1mM Na3VO4)
Sample denaturation should be performed at 70°C for 10 minutes rather than boiling to prevent protein aggregation. Loading 30-50μg of total protein typically provides optimal results for YLR225C detection in wild-type yeast strains .
While immunofluorescence is not explicitly mentioned in the provided antibody specifications, this technique can be adapted for YLR225C localization studies with appropriate optimization. The following protocol provides a starting point:
Cell Fixation: Fix yeast cells with 4% paraformaldehyde for 30 minutes, followed by treatment with zymolyase (100μg/ml) for 30 minutes at 30°C to create spheroplasts.
Permeabilization: Treat cells with 0.1% Triton X-100 in PBS for 5 minutes to allow antibody access to intracellular components.
Blocking: Incubate with 3% BSA in PBS for 30 minutes to reduce non-specific binding.
Primary Antibody: Apply YLR225C antibody at 1:100-1:500 dilution (optimization required) in blocking buffer overnight at 4°C.
Secondary Antibody: Incubate with fluorophore-conjugated anti-rabbit secondary antibody (1:1000) for 1 hour at room temperature.
Counterstaining: Apply DAPI (1μg/ml) for nuclear visualization.
Mounting: Mount in anti-fade medium and seal the coverslip.
Key optimization parameters include antibody concentration, incubation time/temperature, and permeabilization conditions. Controls should include secondary-only samples and, ideally, YLR225C knockout strains. Co-staining with markers for cellular compartments (mitochondria, ER, Golgi, etc.) can provide valuable information about YLR225C localization. Z-stack confocal microscopy is recommended for accurate subcellular localization determination .
The YLR225C antibody has potential applications beyond traditional protein detection in emerging systems biology approaches. Particularly promising areas include:
Interactomics: Using the antibody for immunoprecipitation followed by mass spectrometry to identify protein interaction networks associated with YLR225C under different environmental conditions. This approach could reveal functional relationships currently uncharacterized.
Spatial Proteomics: Combining the antibody with advanced imaging techniques such as super-resolution microscopy or proximity ligation assays to map YLR225C's spatial organization within yeast cells at nanoscale resolution.
Stress Response Characterization: Monitoring YLR225C expression and modification patterns across diverse stress conditions (oxidative, osmotic, thermal) may reveal functional roles in cellular adaptation mechanisms.
Evolutionary Biology: Comparative analysis of YLR225C homologs across fungal species using this antibody (where cross-reactivity exists) could illuminate evolutionary conservation of structure and function.